Science RSS Feeds
Mexico, Aug. 15 (Notimex).- With the participation of scientists from Brazil, Uruguay, Chile, Argentina and Mexico, the symposium "The challenge of neurosciences in Latin America" will be held, with the purpose of disseminating the advances that the research has had in this area. The event is organized by the Center for Research and Advanced Studies (Cinvestav, for its acronym in Spanish) and the Latin American Regional Committee of the International Brain Research Organization (IBRO-LARC). In a statement, the Cinvestav reported that this meeting aims to "analyze the understanding gap between society and governments with neuroscientists, as well as the relevance of their research mainly in countries with emerging economies." The meeting will be held next Friday, August 17, and the general public can attend with previous registration on the website https://desafioneurocienciaslatinoamerica.eventbrite.com.ar Luisa Rocha Arrieta, researcher at the Department of Pharmacobiology of the center, explained that this meeting will expose the need to project their research to solve health problems, as well as to discuss the distance between the neurosciences, governments and supports designated to science. The event is divided into two sessions, the first of them will address the importance of basic science in solving health problems. They will present cutting-edge topics such as the use of stem cells for the repair of the nervous system, or the effective use of new drugs for diseases such as Parkinson, among others. The second session will focus on the importance of science policy and neurosciences in Latin America. "What we consider to be a point in common throughout Latin America, is the need to educate politicians and the population in general, since we believe that as the relevance of doing studies in neurosciences becomes known and disseminated, it will be understood why a drug study can save or improve the quality of a patient´s life,” said the Cinvestav specialist through a statement from the institution. She explained that at a Latin American level, Uruguay may be one of the most advanced countries in this area "for example, they have studies on how to apply marihuana derivatives in different disorders, the government's support is reflected in the quality of their research. NTX/MSG/BBF
Research Network on Telomeres as Sentinels of Environmental Exposures, Psychosocial Stress, and Disease Susceptibility (U24 Clinical Trial Not Allowed)
Telomeres as Sentinels of Environmental Exposures, Psychosocial Stress, and Disease Susceptibility: A Methods Comparison Study (U01 Clinical Trial Optional)
Red Tide Is Killing Marine Life and Scaring Away Tourists in Florida. Here's What to Know About It
Germany has confirmed it will relax some environmental conservation rules to help farmers overcome a sharp rise in animal feed prices after this summer's drought, the agriculture minister said on Wednesday. Agriculture Minister Julia Kloeckner also said she would await official crop figures before deciding on a response to calls for 1 billion euros ($1.13 billion) in crisis state aid requested by German farmers. Kloeckner, a senior member of Chancellor Angela Merkel's conservatives, added she would make a decision about state aid next week when the cabinet is expected to approve the annual harvest report on Aug 22.
Kansas Gov. Jeff Colyer has conceded in the state’s Republican gubernatorial primary, losing by a razor-thin margin to Secretary of State Kris Kobach in a race so close it took a week to determine the winner.
NIH Funding Opportunities
- Limited Competition: RCMI Research Coordination Network (RRCN) (U54 Clinical Trial Not Allowed)
- NLM Information Resource Grants to Reduce Health Disparities (G08 Clinical Trial Not Allowed)
- Leveraging Electronic Medical Records for Psychiatric Genetic Research (R01 Clinical Trial Not Allowed)
- Leveraging Electronic Medical Records for Psychiatric Genetic Research (R01 (Collab) Clinical Trial Not Allowed)
- Notice of the Publication of an NIH Proposal to Amend the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules to Streamline Oversight of Human Gene Transfer Protocols